• 5311 Citations
  • 36 h-Index
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Siqing Fu is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles
Neoplasms Medicine & Life Sciences
Clinical Trials, Phase I Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Mutation Medicine & Life Sciences
Clinical Trials Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

4 Citations (Scopus)

Alisertib in Combination with Weekly Paclitaxel in Patients with Advanced Breast Cancer or Recurrent Ovarian Cancer: A Randomized Clinical Trial

Falchook, G., Coleman, R., Roszak, A., Behbakht, K., Matulonis, U., Ray-Coquard, I., Sawrycki, P., Duska, L. R., Tew, W., Ghamande, S., Lesoin, A., Schwartz, P. E., Buscema, J., Fabbro, M., Lortholary, A., Goff, B., Kurzrock, R., Martin, L. P., Gray, H. J., Fu, S. & 6 others, Sheldon-Waniga, E., Lin, H. M., Venkatakrishnan, K., Zhou, X., Leonard, E. J. & Schilder, R. J., Jan 1 2019, In : JAMA Oncology. 5, 1

Research output: Contribution to journalArticle

Ovarian Neoplasms
Randomized Controlled Trials
Breast Neoplasms
Disease-Free Survival
3 Citations (Scopus)

A phase I/IB trial of the vegfr-sparing multikinase ret inhibitor RXDX-105

Drilon, A., Fu, S., Patel, M. R., Fakih, M., Wang, D., Olszanski, A. J., Morgensztern, D., Liu, S. V., Cho, B. C., Bazhenova, L., Rodriguez, C. P., Doebele, R. C., Wozniak, A., Reckamp, K. L., Seery, T., Nikolinakos, P., Hu, Z., Oliver, J. W., Trone, D., McArthur, K. & 3 others, Patel, R., Multani, P. S. & Ahn, M. J., Mar 1 2019, In : Cancer discovery. 9, 3, p. 384-395 12 p.

Research output: Contribution to journalArticle

Open Access
Non-Small Cell Lung Carcinoma
Gene Fusion
Open Access
Observational Studies
Decision Making
Cross-Sectional Studies

Pharmacokinetics of the Investigational Aurora A Kinase Inhibitor Alisertib in Adult Patients With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic Dysfunction

Zhou, X., Lockhart, A. C., Fu, S., Nemunaitis, J., Sarantopoulos, J., Muehler, A., Rangachari, L., Bargfrede, M. & Venkatakrishnan, K., Jan 1 2019, In : Journal of Clinical Pharmacology. 59, 9, p. 1204-1215 12 p.

Research output: Contribution to journalArticle

Aurora Kinase A